s. We examined the results of coronary artery bypass graft surgery after thromboiytic therapy in the Thromboiysis in Myocardiai Infarction trial, Phase II (TIM1 XI) with particular emphasis on patient characteristics, the impact of antecedent percutaneous transluminai coronary angioplasty and morbidity and mortality in certain subgroups.
variate analysis, the only independent predictor of perioperative mortal was bypass surgery within 24 h after entry or after coronary angiopiasty. Among patients undergoing bypass surgery within 24 h of entry or after coronary angiopiasty, the prevalence of multivessel disease (59.1% vs. 77.8%) and use of the internal thoracic artery (18.5% vs. 62.5%) were lower than in the remaining surgical patients. Among the 322 perioperative survivors, the l-year mortality rate after discharge was only 2.2% and 1.9%, respectively, in the two groups. Only one patient had a doeumented recurrent myocardiai infarction during the first year.
Conclusions. The increased mortality rate with bypass surgery after thromboiytic therapy, particularly in patients undergoing operation within 24 h of coronary angiopiasty or during the invoiviq phase of infarction, must be balanced against tbe excellent I-year prognosis and perioperative survivors, who are in general a group at higher risk of death or recurrent infarction. These data provide a basis for comparisca for future studies.
(J Am Coil Car&l 1995;25:395-402) hypothesis does not explain the strikingly low late mortality. Mechdnisms complementing myocardial salvage have been proposed, including the poteniial for a patent infarct-related artery to have a beneficial effect on ventricu!;r remodeling or electrical stability and to act as a source of future collateral vessels (6,7,Y) . Stringent selection criteria for thromboly?ic therapy may be related to outcome (lo), but the frequent use of coronary revascularization after thrombolytic therapy has been suggested as an additional factor contributing to the low late mortality and cardiac morbidity.
In the Thrombolysis in Myocardial Infarction trial, Phase II (TIM1 II), the administration of the lytic agent was only one aspect, albeit a crucial one, of an overall therapeutic approach that included coronae revascularization by coronary artery bypass graft surgery or percutaneous transluminal coronary angioplasty (11) (12) (13) for appropriate clinica indications. The role of coronary angioplasty has been addressed in several randomized and nonrandomized studies (1 l-15) , but there is relatively little information on the Parly and Iate outcomes of bypass surgery after thromboiytic therapq other tharl reports documenting the feasibility of the technique during the early postlysis period (1.6-21) . Therefore, we examined the results of bypass surgery after thrombolytic therapy in the TIMI II trial, with particular emphasis on the characterislics of the patients selected for coronary bypass, the impact of antecedent coronary angioplasty and morbidity and mortality in speciiic subgroups of patierris.
Methods
Trial design. The TIMI II trial was designed to evaluate the role and timing of angiography and coronary angioplasty in patients treated intravenously with recombinant tissue-type plasminogen activator (rt-PA) within 4 h after an acute myocardial infarction characterized by ST segment elevation at presentation. The primary comparison of management strategies was based on the occurrence of death or myocardial infarction within 42 days of study entry. D&Is of the trial desig,n have been published (Il-13), including a substudy (TIMI IIA) of patients who underwent angiography and coronary angioplasty (when the coronary anatomy was suitable) immediately. In the TlMl IIB s&study, patients eligible for beta-adrenergic blocking ngent therapy were randomly assigned to immediate intravenous administration of metoprolol (started during the rt-PA infusion) followed by oral treatment or deferred oral therapy with metoprolol starting 6 days after i-t-PA infusion (22) .
Patient population. Between April 11, .986 and June 30, 1988,3,339 patients were entered in the TIM1 II t.rial. Of these, 390 underwent coronary bypass within 42 days rfenrollment in TIM1 i1. The population: undergoing coronary bypass evaluated ir: the present analysis irlciudes patients in TIM1 II assigned to either protocol-directed catheterization (206 patients) 18 to 48 h after study entry (invasive strategy) or the conservative strategy of catheterization only when clinically indicated (183 patients).
The details d the administration of rt-P.4, heparin and aspirin; methods of treatment assignment; and managemec: strategies have :+-en :':scribed elsewhere (ll-13,22). Risk of unfavorable outcome was assessed on the basis of age, previous myocardial infarction, anterior myocsrdial infarction, rates, hypctension and tnchycardia, atrial fibrillation or Ilutter, pul. monary edema and cardiogenic shock (11,12,231. B;pass surgery was recommended in the '1'IMI II protocol for invasive strategy group patients with a lumen obstruction 270% in the left main coronary artery (n = IO) or with coronary anatomy that provided technical obstacles co coronaly angioplasty (e.g., distal lesions in a tortuous vessel) in whom bypass surgery was the treatment of choice (n 87). In the ml?jority of patients in tile conservative strategy group, the indications for bypass surgery were brsed on a combination of anatomic findings and clinical observations (e.g., rest or exercise-induced ischemia in patients with ~70% lumen obstruction in more than one major artcry that was perfusing normally, contracting or hypokinetic myocardium and coronary arteries anatomically unsuitable for coronary angioplasiy),
The techniques of anesthesia, coronary @$ass and postoperative management were those in use at the individual institutions participating in the study.
Predismissal and follow-up studies. The techniques for measuring rest left ventricular function aiid for exercise radionuclide ventriculography have been described elacwhere (1 I-13,24). Coronary angiography was performed using standardized projections. Contrast left ventriculography was performed in the 30" to 35" right anterior oblique projection.
Statistical analysis. Proportions were compared by using standard Z tests (25) . Mean values of continuous variables were analyzed by using the Student t test for two-group comparisons. To adjust for multiple testing, two-sided p values between 0.01 and 0.001 were specified as providing some evidence of differences and p < 0.00: as providing strong evidence of differences. Data analyses were performed using the SAS statistical software package (26) and a data file established in January 1991. Survival curves were calculated using the methods of Kaplan and Meier (27) , and comparisons of these rates were tested using the log rank statistic. Perioperative mortality is presented as the percent of patients who died before hospital discharge or within 30 days of bypass surgery.
Comparisons of event rates adjusted for patient characteristics were made with the Cox proportional hazards model (28) lis;n,: BioMedical Data Pack Age (BMDP) program? (29).
Faults
Patient groups. The 3VO patients who underwent bypass srrgery were classified into two groups according to when the operation was perfnrmed: 54 patients who underwent bypass surgery within 24 h after entry into the irial or within 24 h of coronary angioplasty performed within 42 days of enrollment in TIM1 II (group A) and 330 patients who underwent bypass surgery between 24 h and 42 days after entry (group B) ( Table  1) . Perioperative mortality and morbidity were similar between patients operated on between 24 h and 7 days and between days 8 and 42. Therefore, tt,PSe patients were combined into a single group foitl subsequent analyses.
Baseline characteristics. Clinical vutiuabies. Patients undergoing "en?Prgcncy" or "urgent" operation (group A) were younger than thhjse undergoing bypass surgery >24 h after study entry or coronary angioplasty ( Table 1) . The majority of patients in botn groups (63% and 74%) undergoing bypass surgery were considered nnt to be at "low risk" of an adverse 0u:comc.
Cmdiac catkwization variables. PrecTerative coronary angiography was performed in all 390 patients undergoing bypass surgery (206 of whom were assigned to the invasive strategy) ( Table 2 ). The infarct-related artery was the right coronary artery in 42%, the left anterior descenndng coronary artery in -41% and the circumflex coronary artery in 13%. The infarctrelated arteries were similar in the tNo groups (p = 0.83). In 310 patients, the number of vessels diseased was documented; mu!tivessel disease was present in 75% and triple-vessel disease in 28% ( Table 2 ). The Ltistribution of coronary artc;jr d&se amop; patients undergoing bypass surgery in 5iO-F .% was different from that among those Gpraied on L+ter (group 13) (p = 0.018). Single-vessel dust dse was present in 41% of the 44 patients in the former grout, in whom the: coronary ar atomy was reviewed hy TIMI II irr.;. Ltgators for the: study but in only ?ZL of patients undergoing bypass surgery after 24 h (p = NOS). Tine distribution and extent of coronary disease differed strikingly between the patienis in the invasive group undergoing bypass rurgery and the 1,475 patients assigned to the invasive stratcgJr who did not undergo operation. Or the 1,347 patients in the latter group in whom the number of vessels with &O% stenosis was known, only 27% had multivessel disease, and 5% had tr$)le-vessel disease (30) .
Clinical status before bypass surgery. Sixty-three percent of patients undergoing bypass surgery had definite or probable i:ikgina, and of these, 79% were in Cszldian Cardiovascular Society class Iii or KV. This included patients assigned to the invasive strates who underwent protocol-directed catheterization and subseque;it bypass surgery.
In group A F. ::ents (those undergoing bypass surgery within 24 h of study entry or wirXn 24 h of an attempted coronary angioplasty), only 1 (1.8%) of 54 operations was categorized as elective, whereas it was categorized as elective in 66.7% of patients operated on between 24 h and 4: days of study entry. The indications for bypass surgery are presented in Tab!e 3.
The use of intrarlortic balloon counterpulsation in TIMI II was documented for patients undergoing bypass surgcly during the initial TIMI II hospital period. In group A, 58.5% of patients were treated with intraaoriic balloon counterpulsation preoperativeiy, including 13 of the 14 patients reported to be in shock. In the 24-h to 42-day bypass surgery group, 20% of patients in total were treated with intraaortic balloon counterpulsation during their initial hospital stay.
Preoperutivc left ventricihr finnctiotl. Prcaperative ejection fraction determined by contrast ventricufography was avai@le for 43% of patients with bpass surgery and was >0.5Q in 3S%, 0.35 to 0.50 in 46% and co.35 m 19%. Mean ejection fraction was 045 ?Z 0.13 and 0.46 -C 0.12 in groups A and B, respectively. Preoperative ejection fraction from rest radionuciide ventriculography was availablr for 67% of patients and was >0.50 in 55%, 0.35 to 0.50 in 32% and co.35 in l~!'/c~. Xean ejection fraction with this technique was 0.52 zz 0.15 and 0.51 f 0.14 in groups A and B, respectively. When the highest value obtained by either :cchnique was used, 48% of patients had an ejection fraction <0.50; but no measurement of ..'jection fraction was obtained irl 69 of the 390 patients. Coror~ary artery bypass surgery. Mop-wfive morbidity rind monuli6y. Overall, 95% o f patients received saphenous vein grafts and 62% had internal thoracic artery conduits. Of the 369 patients undergoing bypass of the left antcricir descending coronary artery system, 59% had internal thoracic artery conduits Amnr g patients undergoing bypass within 24 h after coromuy angiopkty after entry into the study, the internal :horawc a:tery was used in only 18.5% compared with 62.5% of patients undergoing bypass between 24 h and 42 days. Periopcrathe mortality (defined as death within 30 days or before dismissal from the hospital) was 5.6% overall; it was 16.7% and 3.YCX (p < 0.001) in groups A and 8, respectively (Fig. 1A) . In the 32 patients undergoing operation within 24 h of coronary angioplasty, the perioperative mortality rate was 15.6%. Perioperative myocardial infarction was documented in 5.6% and 6.2% (p = U.96) of patients in groups A and B, 'hblc 3. Indicatiot,s for Bypass Surgery respectively (Table 4 , Fig. 1B ). Perioperative mortality rate is presented in Late events. Among the 322 perioperative survivors, there were only 7 late deaths during the first year, giving rise to l-year mortality rate after discharge of 2.2% and 1.9% (p = 0.88) in groups A and B, respectively. Only one patient had a documented nonfatal recurrent myocardial infarction during the first year. Complete follow-up data are available for TIM1 II patients only through 2 years. In the interval from the end of the first year of follow-up to the beginning of the second year of follow-up, no patients in group A died, and only six patients in group B died.
Adjusted analyses. From the Cox proportional hazards regression models, the only independent predictor of perioperative mortality was the performance of surgery within 24 h after entry into the trial or within 24 h of coronary angioplasty. Other variables examined (none of which was significant) were gender; race; age; anterior infarction; history of previous myocardial infarction, congestive heart failure, hypertension, previous angina or diabetes; and the timing of thrombolytic therapy. No analyses of late events were performed because there were too few late deaths or recurrent infarctions for adjusted analyses.
Discussiom
Frequency of bypass surgery after thrombolytic therapy. A recent meta-analyss (32) suggesitx! thdt for pattcins of g,zc. tice in North America, intravenous thrombolytic therap!-for evolving myocardial infarction is associated with a signikant (,-go%) short-term increase in subsequent coronary revasctllarization procedures compared with patients receiving con- Tables I and 3. ventional therapy. The frequency of bypass surgery during ihe initial hospital stay of patients undergoing :hrombolytic ther spy for acute myocardial infarction was -38% in six series totaling 2,076 patients (33) . In the Interuniversity Cardiology Institute of The Netherlands Trial, during the first 3 years after dismissal, either bypass surgery or coronary angioplasty was performed in 35% of patients treated with thrombolysis and in 27% of patients treated conventionally (34); 17% of the patients in the TIMI I trial underwent bypass surgery during the first year (compared with 16% in this TIM1 II trial), and either bypacs surgery or coronary angioplasty had been performed in -44% at 12 months (35) .
These data emphasize Lurrcnt p;ac!ice trends toward tL I more frequent use of bypass sur;ery as one aspect of a comprehensive therapeutic strafcg: of acute myocardial infarction, with thlombolytic therapy as Ihe first step Characteristics of patients unoerguing hypas-surgeq. Of the 54 patients undergoing operation withm 74 h of entry into the study or after coronary angio$rrty, only 1 patient was categorized as h:Gng an CLXI tie operation. The remainder had either persistent Anna UP PUP &c:i!ic)Tcs after angioplasty. In contrast, in phiiem: ,v, lrpi.;in!: peration within 24 h to 42 days from ent?. --69; vi ,ile pioccdures were categor:s.ed as elective.
As in most surgical series, the majority of pa:icnts had severe angina and multiv:sscl d&case. In patients randomized to the invasive arm, the operation was carried out in accord with the protocol because of crltical coronary obstruction that was not suitable for coronary angioplasty. Among patienis in whom ejection fraction d:Ja were available, left ventricular dysfunction (ejection fra&~l ~0.51)) was present in 65% and 45% of patients by use of contrast ventriculography artd radionuclide anglography, respectively.
Specific indications for bypass s'1rgery were not systematically collected in TIM1 II, particularly because 67 of $U patients undergoing bypass surgery underwent operation after the initial hospital pc~iod. The dais arc therefore confined to patients undergoing operation within the initial hospital period. As illustrated in Table 5 , among group A patients undergoing bypass surgery, this was due to complications of coronary angioplasty in 30 patients and persistent chest pain with ST segment elevation in 12 patients. Among group B patients undergoing operation within 24 h to 42 days, the majsrity of operations were considered elective, but specific details are unavailable.
Distribution of coronary artery disease. In TIMI II, as in many other trials of thrombolytic therapy, only patients with ST segment elevation were eligible for inclusion (12, 14) . In most studies (including TIM1 II), patients with ST segment depression as their o&y presenting electrocardiographic abnormality, a subgroup with a high incidence of multivessel disease (36, 37) , were excluded. Consequently, in this study, as in other trials of thrombolytic therapy, the prevalence of multivessel and particularly triple-vessel disease is low (7,ll) . The more frequent and :lppropriate use of coronary artery bypass surgery in patients with more extensive disease is illustrated by the higher prevalence of multivessel (75%) and triple-vessel (28%) disease in surgically treated patients.
Perioperative morbidity and mortality. In TIM1 II, the higher earlier mortality in patients undergoing bypass surgery within 24 h after study entry or after coronary angioplasty is consistent with other report:5 (38,35) of mortality after emergericy procedures and with the greater prevalence of hypotens;on and cardiogenic shock among these patients. That coronary bq'pzss Furgery within 24 h of a complicated coronary angioplasty is associalcd with a high mortality is not surprising and I!: consistent with other reports. In a recent analysis of the 1989 experience with coronary angioplasty in the state of California, the mortality rate was 12.0% for patients with acute myocardia! infarction who underwent bypass surgery after coronary angioplasty and 5.6% (p = O.WOl b among patients with ;I\macute infarction who underwent operation after coronarl; angiopiasty (40) . Klclman et al. (41) evaluated the mechanisms Jf early death in patients in the TIM1 II trial. Among the ;i3 patients who died within 18 h of stu..iy entry, pump failure wa: the attributed mechanism in 62%. The CORONARY ARTERY BYPASS SURGERY urgency of the surgical procedures could explain the low utilization of the internal thoracic artery as a conduit in this group of patients (20% as opposed to 69% among patients undergoing operation after 24 h). Acute coronary syndromes increase the risk of coronary angioplasty, probably hecause of residual mural thrombus associated with plaque rupture , 11, 14, 42) . The majority of operations performed within 24 h after coronary angioplasty were related to a complication or an unfavorable result of the procedure. Analysis (43) of complications in the National Heart, Lung, and Blood Institute PTCA Registry from 1985 and 1986 showed that the mortality rate for emergencv by-pass surgery was 7.9%, which is substantially less than the 15.2% among patients in this study undergoing operation within 24 h after coronary angioplasty. Comparisons of different series have limitations; nonetheless, these data ell,phasize the risk of bypass surgery for failed coronary angioplasty in postinfarction patients, some of whom will have significant left ventricular dysfunction and multivessel disease.
The TIMI II investigators previously reported (42) that there was an increase in the occurrence of hemorrhagic events associated with invasive procedures after thrombolytic ther.+y. In the present study, there is no specific data suggesting that thrombolytic therapy was responsible for any differences in the occurrence of hemorrhagic events, but it is likely that among patients undergoing bypass surgery within 24 h of study entry, thrombolytic therapy could have contributed to the occurrence of perioperative hemorrhagic events. Nonetheless, the high morbidity and mortality among patients in this group is most likely the consequence of :I greater severity of their initial illness, requiring emergency bypass surgery.
Among patients undergoing bypass surgery later (between 24 h and 42 days after entry), the perioperative mortality (ate of 3.9% is still higher than that found in other series of isolated bypass surgery in patients with chronic stable angina (44, 45) . The explanatisn mcjsl likely is multifactorial and related in :t:*rt to left ventricular dysfunction in patients with recent myocardial infarctior\ and mnltivessel disease (37, 46, 47) . Moreover, the adverse e&t of left ventricular dysfunction on operative mortality during the early postinfarction period was emphasized by Hochberg et a!. (48). Perioperative morta;;sy rates in patients who had an ejection fraction <OS0 were 19%, 18% and 11% in those undergoing bypass rdrgery within 3,4 and 5 weeks after infarction, respectively, ar?d 6% in those undergoing bypass surgery >5 weeks after infarction, Bypass surgery and late mortality. It would appear that the TIM1 surgical population was, in the main, a group with severe coronary disease on the basis of the prevalence of left ventricular dysfunction, multivessel disease, severe angina occurring early after infarction and failure of or unsuitability for coronary anginplasty. Moreover, 24.6% of the patients in the study had a history of myocardial infarction antedating the TIMI infarction, which is considerably higher than the 14% documented among the 3,339 patients in the overall TIMI II trial (49) . A history of previous myocardial infarction is an important predictor of an adverse prognosis after thrombolytic therapy (50). It is thus encouraging to note the very low incidence of late events-only six deaths and one recurrent myocardial infarction at 1 year in perioperative survivors. This is similar to that reported for the overall TIMI II trial of 3,339 patients (49) , in which mortality from 6 weeks to 1 year was 2.2% and the rate of reinfarction was 2.6%.
Conclusions. The TIM1 II study provides detailed data for >390 patients undergoing bypass silrgery within 6 weeks of thrombolytic therapy. The high mortaliQ.in patients undergoing operation within 24 h of coronary angloplasty or during the evolving phase of infarction is emphasized. In patients undergoing bypass surgery between 24 h and 42 days after entry, the mortality rate of 3.2% is increased compared with that in other series of patients with chronic stable angina, but this must be balanced against the excellent l-year prognosis in perioperative sutivors, who were, in general, a group at high risk ol death or recurrent infarction. These observations cannot necessarily be extended to all patients undergoing bypass surgery after myocardial infarction (with or without thrombolytic therapy), but the data provide a basis for comparison with future studies.
